Health
Insilico Medicine AI COVID tool uses Xeons – Fudzilla
Intel helps in COVID-19 research Industry veteran Alex Zhavoronkov who left the PC industry (ATI and AMD) to start the AI longevity focused Insilico Medicine, has announced AI-powered COVIDomic to power the COVID-19 basic and clinical research.
Insilico Medicine is a global leader in artificial intelligence for drug discovery and development, and the company is among the first in the world to embrace the AI technologies in tools in drug discoveries. Now the company realized that it could use AI on Intel Xeon architecture to launch a new system for COVID-19 basic and clinical research.
Insilico Medicine came up with COVIDomic, a foundational technology that enables scientists to use anonymized patient data to integrate with a variety o…
-
Business19 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News18 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News15 hours agoTips to improve engagement – Proctor
-
General19 hours agoMelbourne synagogue fire shows Australia’s multicultural project needs urgent help